Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2011-06-21
2011-06-21
Qazi, Sabiha (Department: 1612)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C554S167000, C554S221000, C514S549000
Reexamination Certificate
active
07964639
ABSTRACT:
A method of minimizing or reducing the toxicity of a retinoid having a free carboxyl group and the resulting modified retinoids are described. The method comprises the step of esterifying the carboxyl group of the retinoid with a highly sterically hindered compound, which is preferably a secondary or tertiary alcohol. The resulting retinoid esters are rendered much less toxic than the starting or parent retinoid. This process provides a retinoid ester analog of reduced toxicity so that it may be administered orally with minimal side effects and with a much greater therapeutic window. The modified retinoid compounds are useful in the treatment and prophylaxis of all diseases and disorders where retinoid compounds have been shown effective.
REFERENCES:
patent: 3984544 (1976-10-01), Casmer et al.
patent: 4126699 (1978-11-01), Gander et al.
patent: 4190594 (1980-02-01), Gander et al.
patent: 4677120 (1987-06-01), Parish et al.
patent: 4885311 (1989-12-01), Parish et al.
patent: 4994491 (1991-02-01), Purcell et al.
patent: 5049584 (1991-09-01), Purcell et al.
patent: 5124356 (1992-06-01), Purcell et al.
patent: 5837728 (1998-11-01), Purcell
patent: 7126017 (2006-10-01), DeLuca et al.
patent: 7750043 (2010-07-01), DeLuca et al.
patent: 7763599 (2010-07-01), DeLuca et al.
patent: 2050658 (1972-05-01), None
patent: 0 337 689 (1989-10-01), None
patent: WO 92/12989 (1992-08-01), None
Bagley et al, “Fourier-Transform Infrared Difference Spectroscopy of Rhodopsin and Its Photoproducts at Low Temperature,” Biochemistry, vol. 24, pp. 6055-6071, (1985).
Singh, “A Convenient and Improved Method for the Preparation of Retinoates,” Synthetic Communications, vol. 12, pp. 447-451, (1982).
Singh, “Extrinsic Circular Dichroic Effects in Retinoates,” Journal of the Chemical Society, Perkin Transactions 2, pp. 635-636, (1986).
Tsutsumi, “Positive-Type Resist Composition with Good Dry-Etching Resistance for Far Ultraviolet Ray and Manufacture of Semiconductor Integrated Circuit Using It,” Chemical Abstracts, XP002285682, (1997).
Clagett-Dame Margaret
DeLuca Hector F.
Gowlugari Sumithra
Andrus Sceales Starke & Sawall LLP
Qazi Sabiha
Wisconsin Alumni Research Foundation
LandOfFree
Modified retinoid compounds and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified retinoid compounds and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified retinoid compounds and their uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2647132